A Clinical Study for the Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen in Patients With Metastatic Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tamoxifen (Primary)
- Indications Advanced breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 12 Feb 2010 Planned end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Actual initiation date (Jun 2006) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.